PRESS RELEASE
Published on June 17, 2003
EXHIBIT 6
CONTACT: WALISA M. DAVENPORT
EXEGENICS INC.
(214) 358-2000
E. BLAIR CLARK (INVESTORS)
BURNS MCCLELLAN
(212) 213-0006
WILLIAM FISKE (INFORMATION AGENT)
GEORGESON SHAREHOLDER COMMUNICATIONS INC.
BANKS AND BROKERS: (212) 440-9800
ALL OTHERS CALL TOLL-FREE: (800) 964-0733
EXEGENICS ANNOUNCES OVERWHELMING SHAREHOLDER VOTE IN FAVOR OF CURRENT DIRECTORS
MORE THAN 96% OF SHARES VOTED TO APPROVE MAINTAINING PRESENT BOARD
DALLAS, June 17, 2003 -- EXEGENICS, Inc. (Nasdaq: EXEG) announced today the
results of voting at its 2003 annual meeting of stockholders, which was
adjourned from May 19th and held today. The purpose of the meeting was to elect
all directors to serve for one-year terms expiring in 2004, and to ratify the
appointment of Ernst & Young LLP as the company's independent public accountants
for the fiscal year ending December 31, 2003. The company reported that over 87%
of shares owned by stockholders of record voted in person or by proxy at the
meeting. Of those shares voted, over 96% were in favor of the nominees (Dr.
Joseph Davie, Mr. Robert Easton, Dr. Ronald Goode, and Dr. Walter Lovenberg)
recommended by the board of directors. The appointment of Ernst & Young LLP as
the Company's independent public accountants was ratified by 99% of the shares
voted.
Ronald L. Goode, Ph.D., chairman, president and CEO said, "We are pleased that
stockholder's have endorsed the current slate of directors, in accordance with
the Board's recommendation. We believe that this vote is indicative of our
willingness to work with and for shareholders to complete a systematic
consideration of ways to maximize value for our shareholders. Further, we
believe that this vote serves as a mandate to reject offers, such as that made
by EI Acquisition Inc. and Foundation Growth Investments LLC, that we consider
inadequate." With regard to that tender offer, Dr. Goode commented that "For
all the reasons set forth in my letter sent to shareholders on June 12th, the
Board continues to encourage all shareholders to reject Foundation's offer and
to not tender their shares."
EXEGENICS' stockholders are asked to read the Solicitation/Recommendation
Statement that was filed by EXEGENICS with the Securities and Exchange
Commission on June 12, 2003 and mailed to stockholders. It explains in more
detail the recommendation and why EXEGENICS' board of directors feel so strongly
that stockholders should REJECT Foundation's offer and not tender their shares.
ANY QUESTIONS OR REQUESTS FOR ASSISTANCE IN THIS MATTER SHOULD BE DIRECTED TO
EXEGENICS' INFORMATION AGENT: GEORGESON SHAREHOLDER COMMUNICATIONS, INC., 17
STATE STREET, 10TH FLOOR, NEW YORK, NY 10004; BANKS AND BROKERS CALL: (212)
440-9800; ALL OTHERS CALL TOLL-FREE: (800) 964-0733.
SAFE HARBOR
This release contains forward-looking statements. The words "believe," "expect,"
"intend", "anticipate," variations of such words, and similar expressions
identify forward-looking statements, but their absence does not mean that the
statement is not forward-looking. These statements are subject to certain risks,
uncertainties and assumptions that are difficult to predict. Readers are
cautioned not to place undue reliance on these forward-looking statements, which
speak only as of the date of this release. eXegenics undertakes no obligation to
update any forward-looking statement to reflect new information, events or
circumstances after the date of this release or to reflect the occurrence of
unanticipated events.